An experimental personalized mRNA-based cancer vaccine from Merck and Moderna was successful at preventing melanoma from returning or spreading in a late-stage trial of high risk patients, the companies announced Wednesday. The positive results mean a potentially life-extending treatment is one step closer to being available on the market. They also herald a significant and…
Politics
·
Moderna, Merck mRNA cancer vaccine prevents melanoma from returning
CN
CitrixNews Staff
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Politics
Cyclosporiasis cases now total 15,716: CDC
The number of cyclosporiasis cases in the U.S. has now climbed to more than 15,000, according to the Centers for Disease...
CitrixNews Staff
·
14 minutes ago
Politics
De Blasio: DSA ‘providing vision’ many in US ‘hungry for’
Former New York City Mayor Bill de Blasio (D) on Tuesday said the Democratic Socialists of America (DSA) are “providing ...
CitrixNews Staff
·
20 minutes ago
Politics
DOJ defends Comey prosecution, says ‘no serious dispute’ Trump post could be seen as a threat
The Justice Department discouraged a judge from tossing a case against former FBI Director James Comey, saying it should...
CitrixNews Staff
·
28 minutes ago
Politics
Democrats shied away from faith voters for years — that’s finally changing
As Christian nationalism grows within the Republican Party, Democratic candidates are increasingly engaging religious vo...
CitrixNews Staff
·
38 minutes ago